Search | IOVS | ARVO Journals

View

Showing 1 – 14 of 14

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

The Reducing Adenoviral Patient-Infected Days (RAPID) Study: Safety and Tolerability of One-Time, In-Office Application of 5% Povidone-Iodine in the Treatment of Adenoviral Conjunctivitis

Ellen Shorter; Tammy Than; Meredith Whiteside; Jennifer S Harthan; Mathew Margolis; Spencer Johnson; Mary Migneco; Christina Morettin; Christian K. Olson; Andrew Hartwick; Julia Huecker; Mae O Gordon

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4703. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Reducing Adenoviral Patient-Infected Days (RAPID) Study: A Randomized Trial Assessing Efficacy of One Time, In-Office Application of 5% Povidone-Iodine in Treatment of Adenoviral Conjunctivitis

Andrew Hartwick; Tammy Than; Bojana Rodic-Polic; Spencer Johnson; Mary Migneco; Ellen Shorter; Jennifer S Harthan; Christina Morettin; Meredith Whiteside; Christian K. Olson; Mathew Margolis; Julia Huecker; Gregory Storch; Mae O Gordon

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6257. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2018

Reducing Adenoviral Patient Infected Days (RAPID): Prevalence of Polymerase Chain Reaction (PCR) Confirmed Adenovirus Among Patients Presenting With Acute Conjunctivitis

Mary Migneco; Mathew Margolis; Christina Morettin; Tammy Than; Meredith Whiteside; Ellen Shorter; Jennifer S Harthan; Spencer Johnson; Andy Hartwick; Kelly Olsen; Tave van Zyl; Julia Huecker; Crystal Rosemann; Mae O. Gordon

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):115. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2018

Reducing Adenoviral Patient Infected Days (RAPID) Study: Success in Masking Subjects and Clinicians From Identifying Treatment with Ophthalmic Povidone-Iodine 5% (PVP-I).

Meredith Whiteside; Ellen Shorter; Mary Migneco; Andy Hartwick; Tammy Than; Jennifer S Harthan; Christina Morettin; Spencer Johnson; Mathew Margolis; Julia Huecker; Kelly Olsen; Crystal Rosemann; Tave' van Zyl; Timothy Bossie; Mae Gordon

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3788. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2017

Reducing Adenoviral Patient Infected Days (RAPID) Study: Association of Clinical Signs and Symptoms with qPCR confirmed Adenoviral Conjunctivitis

Ellen Shorter; Mary Migneco; Jennifer S Harthan; Meredith Whiteside; Christina Morettin; Tammy Than; Spencer Johnson; Julia Huecker; Andrew T E Hartwick; Mae O Gordon

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4360. doi: https://doi.org/

ARVO Annual Meeting Abstract September 2016

Reducing Adenoviral Patient Infected Days (RAPID) Planning Study: Agreement between Clinician and AdenoPlus TM in the Diagnosis of Adenoviral Conjunctivitis

Mary Migneco; Mae O Gordon; Andrew T E Hartwick; Spencer Johnson; Jennifer Harthan; Christina Morettin; Tammy Than; Ellen Shorter; Julie Huecker

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3503. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2013

Correlations between non-stimulated tear levels and conjunctival surface expression of inflammation-related biomarkers in normal and aqueous-deficient dry eye patients

Roderick Fullard; John Bradley; Larezia Williams; My-Tho Tran; Nicole Guyette; Tammy Than; Pearl Shin

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4360. doi: https://doi.org/

Cornea May 2013

Comparison of Low-Abundance Biomarker Levels in Capillary-Collected Nonstimulated Tears and Washout Tears of Aqueous-Deficient and Normal Patients

PDF

Nicole Guyette; Larezia Williams; My-Tho Tran; Tammy Than; John Bradley; Lucy Kehinde; Clara Edwards; Mark Beasley; Roderick Fullard
TAGS: cytokine, biological markers, dry eye syndromes, blood capillaries
Invest. Ophthalmol. Vis. Sci.. 2013; 54(5):3729-3737. doi: https://doi.org/10.1167/iovs.12-11431

ARVO Annual Meeting Abstract March 2012

Conjunctival Gene Expression Patterns in Dry Eye; Real Time PCR and Beyond

John L. Bradley; Keshia S. Elder; Tammy P. Than; Roderick J. Fullard

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):538. doi: https://doi.org/

ARVO Annual Meeting Abstract March 2012

Non-stimulated Tear Levels and Conjunctival Expression of IL-8 and IP-10 in Normal and Dry Eye Patients

Roderick J. Fullard; My-Tho K. Tran; Larezia D. Williams; John L. Bradley; Nicole M. Guyette; Tammy P. Than; Roy Joseph; Landon S. Wilson; Stephen Barnes

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):539. doi: https://doi.org/

ARVO Annual Meeting Abstract March 2012

Impedance Osmometry: Standard Solutions

William J. Benjamin; Tammy P. Than

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):562. doi: https://doi.org/

ARVO Annual Meeting Abstract March 2012

Effects of Nicotine on Flicker ERGs: Application of DFT and T-Circ2

Stefanie B. Varghese; Naser Naser; Tammy P. Than; Kent T. Keyser; E. Eugenie Hartmann

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5702. doi: https://doi.org/

ARVO Annual Meeting Abstract April 2011

Color Vision: Effects of Nicotine Gum in Non-Smokers

Naser T. Naser; Michael Loop; Tammy Than; Stefanie Varghese; E. E. Hartmann

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4902. doi: https://doi.org/

ARVO Annual Meeting Abstract April 2011

Correlations between Tear IP-10 and other Biomarkers in Normal and Dry Eye Patients

Tammy P. Than; Nicole Guyette; Karin Tran; Keshia Elder; Janene Sims; Lucy Kehinde; Pearl Shin; Larezia Williams; John Bradley; Roderick Fullard

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3807. doi: https://doi.org/

Advertisement